돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 465081생성일: 2026년 10월 26일

Triethylamine → 11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one

https://huagongshe.com/reaction/465081

반응식

참여 물질

역할이름HCID투입량
반응물TriethylamineHCID 8471—
반응물Ethyl chloroformateHCID 10928—
반응물Sodium HydroxideHCID 14798—
반응물5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oneHCID 70169—
용매TetrahydrofuranHCID 8028—
생성물11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oneHCID 10786729.9%

반응 조건

온도0 °C

반응 단계

Ethyl chlorocarbonate (11.0 g, 0.101 mol) is added dropwise, at 0° C., to a suspension of 2-[(diethylamino)methyl]-1-piperidino acetic acid (22.83 g, 0.1 mol) in dry tetrahydrofuran (200 ml). Then, 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one (21.12 g, 0.1 mol) and triethylamine (20.24 g, 0.2 mol) are added to the resulting suspension which is then stirred for a further hour at 0° C. and then for 4 hours at ambient temperature. The mixture is poured into 2N sodium hydroxide solution (1.6 liters), extracted exhaustively with dichloromethane, the organic phase concentrated to dryness and the residue purified by recrystallization from ethanol and from methanol. Colorless crystals (6.3 g) are obtained, mp. 226°-228° C., which were shown by thin layer chromatography, mixed melting point and IR spectrum to be identical to a sample prepared according to Example 34.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04550107
출처 데이터셋uspto-grants-1985_10
ORD IDord-901753c25af7418f9c10fcb008b79f6c
출처 메모uspto-grants-1985_10